Trial Profile
A Placebo-controlled, Double-blind, Randomized Trial of an Intra-articular Device, SB-061, in Symptomatic Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs SB 061 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms MODIFY-OA
- Sponsors Symic Bio
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 18 May 2017 Results from this trial published in a Symic Bio Media Release.
- 25 Apr 2017 Planned End Date changed from 1 May 2017 to 1 Jun 2017.